All the good news is in the current price of ABT. The entire drug sector is overvalued. I hold many of the major drug companies and am holding for the long term. But to buy at these prices, it just does not make any sense.
To the contrary, I believe ABT is undervalued. Nearly $12 billion in sales last year, expected higher eps this next quarter, relatively low P/E ratio, what's to prevent a price breakout to $100/share ?